Advertisement
Screener

Jazz Pharmaceuticals plc (JAZZ) Cash Flow Breakdown

Jazz Pharmaceuticals plc Cash Flow Breakdown

Cash flow breakdown shows where Jazz Pharmaceuticals plc's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $1.36B came in.
  • Fiscal year ended 2025-12-31: from investing, $1.51B went out.
  • Fiscal year ended 2025-12-31: from financing, $873.38M went out.
  • Fiscal year ended 2025-12-31: change in cash, $1.02B went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31$1.36B-$1.51B-$125.02M-$75.22M-$673.14M*-$1.02B
2024-12-31$1.40B-$508.19M-$311.43M-$57.75M$389.70M*$906.55M
2023-12-31$1.09B-$163.06M-$269.76M$0.00-$50.95M$15.46M*$624.83M
2022-12-31$1.27B-$446.23M-$54.00K$0.00$0.00*-$45.44M-$483.99M*$290.03M
2021-12-31$778.51M-$5.21B$0.00$1.47B$0.00*-$35.60M$2.53B*-$466.32M
2020-12-31$899.65M-$1.01B-$146.54M$0.00$0.00*-$16.88M$691.49M*$420.43M
2019-12-31$776.40M-$155.30M-$301.45M$0.00$0.00*-$16.74M$24.44M*$327.72M
2018-12-31$798.90M-$394.49M-$523.67M$0.00$0.00*-$17.93M$62.47M*-$76.41M
2017-12-31$693.09M-$268.95M-$98.80M$559.39M-$850.00M-$18.59M-$1.12M*$20.07M
2016-12-31$592.39M-$1.75B-$278.30M$994.65M-$150.00M-$21.23M-$4.13M*-$622.82M
2015-12-31$531.94M-$2.25M-$61.55M$898.64M-$160.00M-$26.10M$0.00-$865.31M*$304.74M
2014-12-31$407.61M-$1.07B-$42.22M$1.19B-$300.00M-$18.03M-$123.11M*$47.54M
2013-12-31$288.43M-$16.26M-$136.48M$0.00$553.42M$0.00-$5.59M$0.00-$435.21M*$249.31M
2012-12-31$249.75M-$395.29M$0.00$0.00$450.92M$0.00-$25.30M$0.00$9.79M$13.13M*$305.12M
2011-12-31$151.60M-$81.23M$0.00-$483.00K$0.00$0.00$0.00$0.00-$32.60M*$37.28M
2010-12-31$58.87M-$2.14M-$8.48M$0.00$56.82M$0.00-$75.86M*$29.20M
2009-12-31-$15.88M-$6.12M$6.78M$5.91M*-$9.31M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$415.70M*$354.90M*-$9.50M*-$985.00M*
2026-03-31$408.20M$123.10M-$103.60M$25.10M*$452.40M
2025-12-31$362.52M*-$372.16M*$0.00*-$2.00M*$77.44M*
2025-09-30$474.65M*-$327.75M*-$23.00K*-$3.82M*-$7.07M*
2025-06-30$88.80M*-$641.00M*-$2.20M*-$122.20M*
2025-03-31$429.80M-$169.00M-$67.20M-$746.30M*-$551.00M
2024-12-31$398.58M*-$193.29M*$0.00*-$4.00M*-$4.27M*
2024-09-30$398.75M*$214.09M*-$150.00M*-$1.60M*$398.03M*
2024-06-30$331.35M*-$257.09M*-$2.85M*-$158.24M*
2024-03-31$267.23M-$271.90M-$49.30M-$7.26M*-$62.92M
2023-12-31$167.34M*$101.80M*-$99.80M*-$1.61M*$1.10M*
2023-09-30$307.19M*-$174.30M*-$74.37M*-$1.88M*-$2.24M*
2023-06-30$296.76M*-$85.74M*-$4.19M*-$92.48M*
2023-03-31$320.71M-$4.82M-$43.27M$13.48M*$286.43M
2022-12-31$341.97M*-$324.38M*$0.00*$0.00*-$2.81M*$22.41M*
2022-09-30$417.99M*$4.60M*$0.00*$0.00*-$2.57M*-$286.49M*
2022-06-30$303.04M*-$89.16M*-$6.29M*$17.07M*
2022-03-31$208.98M-$37.29M-$33.78M-$237.03M*-$100.61M
2021-12-31$177.75M*-$10.09M*$0.00*$0.00*$0.00*-$6.00M*-$240.61M*
2021-09-30$274.06M*-$26.81M*$0.00*$0.00*$0.00*-$2.43M*-$462.75M*
2021-06-30$41.70M*-$5.91B*$0.00*-$3.39M*$4.67B*
2021-03-31$285.00M$737.13M$0.00-$23.78M$42.06M*$1.04B
2020-12-31$186.27M*$73.22M*$0.00*$0.00*$0.00*-$1.12M*$56.99M*
2020-09-30$257.89M*-$279.64M*$0.00*$0.00*$0.00*-$1.10M*-$21.56M*
2020-06-30$182.52M*-$741.16M*-$7.48M*-$1.12M*$651.13M*
2020-03-31$272.97M-$60.08M-$139.05M-$13.55M$4.92M*$64.26M
2019-12-31$87.80M*-$159.05M*-$110.33M*$0.00*-$839.00K*$23.39M*
2019-09-30$337.50M*-$159.66M*-$20.00M*$0.00*-$1.09M*$1.62M*
2019-06-30$148.85M*-$2.64M*-$59.87M*-$1.00M*$4.72M*
2019-03-31$202.25M$166.05M-$111.25M-$13.81M-$5.29M*$237.84M
2018-12-31$218.10M*$39.99M*-$446.66M*$0.00*$0.00*-$733.00K*-$189.40M*
2018-09-30$221.47M*-$191.75M*-$21.45M*$0.00*-$1.17M*$8.65M*$13.94M*
2018-06-30$191.97M*-$190.58M*-$21.02M*$0.00*-$1.43M*$51.32M*$31.91M*
2018-03-31$167.36M-$52.15M-$34.55M$0.00-$14.59M$1.56M*$67.13M
2017-12-31$204.56M*-$31.88M*-$42.37M*-$91.00K*$0.00*-$680.00K*$3.16M*$133.42M*
2017-09-30$188.90M*-$203.35M*-$25.57M*-$500.00M*-$1.59M*$554.18M*$13.40M*
2017-06-30$135.09M*-$30.15M*-$16.96M*-$200.00M*-$1.89M*$4.37M*-$107.78M*
2017-03-31$164.54M-$3.57M-$13.90M-$150.00M-$14.43M-$3.35M*-$18.97M
2016-12-31$180.69M*-$1.86M*-$18.48M*-$130.00K*-$150.00M*-$639.00K*-$2.80M*-$604.00K*
2016-09-30$133.03M*-$1.53B*-$96.58M*$994.78M*$0.00*-$6.32M*-$3.50M*$6.84M*-$501.40M*
2016-06-30$127.01M*-$206.27M*-$28.88M*$0.00*-$1.80M*-$4.43M*$5.38M*-$111.81M*
2016-03-31$151.65M-$11.99M-$134.37M$0.00-$12.48M-$5.62M*-$9.01M
2015-12-31$119.74M*-$3.37M*-$40.25M*-$318.00K*-$80.00M*-$700.00K*$320.00K*-$2.91M*-$10.07M*
2015-09-30$175.08M*-$5.16M*-$9.61M*-$2.04M*-$8.72M*-$320.00K*-$73.73M*$77.22M*
2015-06-30$140.57M*-$12.02M*-$1.35M*$901.00M*-$1.90M*-$10.63M*-$879.89M*$139.04M*
2015-03-31$96.56M$18.29M-$10.34M$0.00-$14.78M$10.63M$11.22M*$98.56M
2014-12-31$134.26M*-$14.17M*-$12.24M*-$981.00K*$0.00*-$724.00K*-$2.23M*$5.74M*$109.00M*
2014-09-30$129.70M*-$83.14M*-$6.49M*$559.01M*-$6.75M*$3.28M*-$285.79M*$306.79M*
2014-06-30$74.92M*-$13.13M*-$23.49M*$0.00*-$1.19M*-$4.99M*-$9.79M*$22.38M*
2014-03-31$68.72M-$957.20M$0.00$636.36M-$9.36M$5.78M-$135.11M*-$390.63M
2013-12-31$79.03M*-$3.10M*-$34.09M*$0.00*$0.00*-$287.00K*-$82.00K*$5.73M*$48.04M*
2013-09-30$130.79M*-$3.15M*-$48.82M*$0.00*-$3.71M*$82.00K*$6.72M*$84.16M*
2013-06-30$8.72M*-$3.57M*$553.42M*-$170.00K*-$889.00K*-$504.91M*$53.80M*
2013-03-31$69.89M-$6.44M$0.00-$1.43M$889.00K$3.67M*$63.31M
2012-12-31$104.34M*$87.19M*$0.00*$0.00*$0.00*$5.52M*-$1.93M*$197.40M*
2012-09-30$44.14M*-$3.75M*$0.00*$0.00*-$1.97M*-$3.52M*$35.25M*
2012-06-30$76.97M*-$561.24M*$0.00*$4.32M*$464.33M*-$16.11M*
2012-03-31$24.30M$82.51M-$25.30M$1.91M$5.16M*$88.58M
2011-12-31$43.66M*-$65.60M*-$150.00K*$0.00*$0.00*$2.95M*-$19.14M*
2011-09-30$46.05M*-$13.62M*-$33.61M*-$1.18M*
2011-06-30$37.44M*-$820.00K*$719.00K*$37.34M*
2011-03-31$24.45M-$1.19M-$2.99M*$20.27M
2010-12-31$22.79M*-$1.11M*$0.00*$0.00*$21.94M*
2010-09-30$18.49M*-$806.00K*$0.00*-$302.00K*-$4.10M*$13.28M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Viatris Inc (VTRS)United States$20.008B-0.00
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28